International Clinical Trial: A Phase II Clinical Study to Evaluate the Efficacy and Safety of YKYY018 for Inhalation Solution

Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07808268) titled 'A Phase II Clinical Study to Evaluate the Efficacy and Safety of YKYY018 for Inhalation Solution' on Sept. 2.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Double (Participant, Investigator).

Primary Sponsor: Beijing Youcare Kechuang Pharmaceutical Technology Co., Ltd.

Condition: Respiratory Syncytial Virus (RSV)

Intervention: Drug: YKYY018 for Inhalation Solution

Recruitment Status: Not recruiting

Phase: Phase 2

Date of First Enrollment: October 10, 2026

Target Sample Size: 160

Countries of Recruitment: C...